Advertisement

Topics

Biomed Company Profile

08:34 EST 11th December 2018 | BioPortfolio

Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpflichtigen sowie freiverkäuflichen pflanzlichen Medikamenten und Mineralstoff-Präparaten und nimmt in diesen Bereichen eine führende Stellung ein. Aber auch Vitamine, Medikamente zur Behandlung von Durchfallerkrankungen, Insektenstichen und Produkte für die Mundhygiene gehören zum Sortiment der Biomed.
Hinter dem Biomed Leitmotiv NATUR & WISSEN steht die Absicht, natürliche Medikamente und Stoffe zu fördern und mit modernster Wissenschaft zu kombinieren, um sie sowohl zur Heilung von Krankheiten als auch zur Erhaltung der Gesundheit einzusetzen.

Die Partner von Biomed sind Ärzte, Spitäler, Apotheken, Drogerien. Ihnen wollen wir verlässliche, kompetente und engagierte Partner sein.

Contact

Phone: 41 44 16 16
Fax: 41 4 802 16 00
Email: blomed@blomed.ch


News Articles [131 Associated News Articles listed on BioPortfolio]

Q BioMed Acquires Cancer Pain Drug From GE Healthcare

NewsThe acquisition of Metastron gives Q BioMed ownership of the drug and related market authorizations in 22 countries.Contributed Author: 

Harbour BioMed gets rights to Glenmark's bispecific antibody

Glenmark Pharmaceuticals SA granted Harbour BioMed exclusive rights to develop and sell its bispecific antibody GBR1302 for solid tumors in Greater China. Harbour BioMed also retains a manufacturing o...

Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline

Harbour BioMed is engaged in the discovery and development of therapeutics for oncology and immunological diseases. The financing round was led by GIC Private Limited, and participants included The p...

Siloam Biosciences to be acquired by MiCo BioMed

South Korea-based MiCo BioMed, which makes biochemical and molecular diagnostic products, announced its acquisition of Cincin -More- 

Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug

Q BioMed Inc (OTCQB: QBIO) CEO Denis Corin tells Proactive Investors the commercial-stage biotech is taking the final step in the approval process of its bone pain relief treatment, the "spearhead'"...

Orchestra BioMed secures $41m funding for cardiovascular product candidates

Orchestra BioMed will use the funding to support continued late-stage clinical development of its Virtue sirolimus-eluting balloon (SEB) to treat artery disease and BackBeat cardiac neuromodulation th...

Q BioMed’s Metastron acquisition ‘positive development,’ advances pipeline, says Brookline Capital Markets

Analyst Kumaraguru Raja says Q BioMed’s ownership of this non-opioid cancer pain drug will give it ‘immediate, established, and long-term revenue’

Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology

Harbour BioMed has signed a collaboration agreement with Kelun-Biotech Biopharmaceutical to develop and commercialise A167, an anti-PD-L1 antibody indicated for...Read More... The post Deals this week...

Drugs and Medications [0 Results]

None

PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

Comment on "Using Innovative Acoustic Analysis to Predict the Postoperative Outcomes of Unilateral Vocal Fold Paralysis".

Corrigendum to "Carnitine/organic cation transporter 2 (OCTN2) contributes to rat epididymal epithelial cell growth and proliferation" Biomed. Pharmacother. 93(2017):444-450.

BITS 2017: the annual meeting of the Italian Society of Bioinformatics.

This preface introduces the content of the BioMed Central journal Supplement related to the 14th annual meeting of the Bioinformatics Italian Society, held in Cagliari, Italy, from the 5th to the 7th ...

Quercetin Stimulates Bone Marrow Mesenchymal Stem Cell Differentiation through an Estrogen Receptor-Mediated Pathway.

The present study aimed to investigate the overall effect of quercetin on mouse bone marrow mesenchymal stem cell (BMSC) proliferation and osteogenic differentiation .

Partially systematic thoughts on the history of systematic reviews.

Six years after the launch of Systematic Reviews by Biomed Central, this article is part of the celebration of the journal. It contains personal reflections on the past, present and future of systemat...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

WarmSmart Warming Protocol

Hypothermia during surgery and in the postoperative period is associated with adverse outcomes including impaired drug metabolism, cardiac morbidity, shivering, impaired immune function, c...

Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

Protocol 777-CLP-32 is the treatment and survival continuation protocol of Biomed 777-CLP-29, and will continue to compare combined hormonal therapy using the experimental aromatase inhibi...

Color Stability of NeoMTA Pulpotomized Primary Teeth

This randomized control study will use 15 pediatric subjects selected from the patient population in the pediatric dental clinic at Children's Medical Center Dental Clinic (CMC Dental Clin...

Companies [47 Associated Companies listed on BioPortfolio]

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

Biomed

Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpfl...

Alpine Biomed Corporation

Alpine Biomed is a global leader in specialty diagnostic devices for the gastroenterology and neurology clinical markets. The company produces diagnostic tools used for gastroesophageal reflux diseas...

BioMed Capital Group Ltd.

BioMed principals and affiliates understand the strategic factors that drive future performance, including: Competition and competitive advantages Technology as related to markets served Capital requ...

More Information about "Biomed" on BioPortfolio

We have published hundreds of Biomed news stories on BioPortfolio along with dozens of Biomed Clinical Trials and PubMed Articles about Biomed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biomed Companies in our database. You can also find out about relevant Biomed Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record